Mario Santiago
Concepts (394)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Friend murine leukemia virus | 17 | 2021 | 30 | 6.290 |
Why?
| Retroviridae Infections | 21 | 2024 | 46 | 5.710 |
Why?
| Cytidine Deaminase | 21 | 2024 | 58 | 5.510 |
Why?
| HIV-1 | 29 | 2024 | 768 | 3.370 |
Why?
| Virus Replication | 19 | 2024 | 395 | 2.700 |
Why?
| Antibodies, Neutralizing | 10 | 2022 | 221 | 2.630 |
Why?
| Simian Immunodeficiency Virus | 19 | 2015 | 70 | 2.010 |
Why?
| Antiviral Agents | 9 | 2022 | 645 | 1.990 |
Why?
| HIV Infections | 21 | 2024 | 2469 | 1.980 |
Why?
| Interferon-alpha | 7 | 2020 | 186 | 1.950 |
Why?
| Antibodies, Viral | 12 | 2022 | 520 | 1.910 |
Why?
| Somatic Hypermutation, Immunoglobulin | 3 | 2022 | 17 | 1.770 |
Why?
| Simian Acquired Immunodeficiency Syndrome | 11 | 2015 | 68 | 1.670 |
Why?
| Antigens, CD | 5 | 2016 | 442 | 1.620 |
Why?
| Tumor Virus Infections | 8 | 2024 | 43 | 1.520 |
Why?
| Dendritic Cells | 5 | 2020 | 435 | 1.460 |
Why?
| Gastrointestinal Tract | 3 | 2022 | 169 | 1.430 |
Why?
| Immunity, Innate | 12 | 2024 | 720 | 1.270 |
Why?
| Adaptive Immunity | 3 | 2021 | 155 | 1.250 |
Why?
| Membrane Glycoproteins | 3 | 2016 | 430 | 1.170 |
Why?
| Interferon Type I | 7 | 2022 | 128 | 1.140 |
Why?
| CD4-Positive T-Lymphocytes | 11 | 2022 | 959 | 1.030 |
Why?
| Interferons | 3 | 2024 | 151 | 1.000 |
Why?
| Pan troglodytes | 11 | 2009 | 47 | 0.950 |
Why?
| SAM Domain and HD Domain-Containing Protein 1 | 2 | 2021 | 4 | 0.940 |
Why?
| Mice, Inbred BALB C | 11 | 2024 | 1143 | 0.840 |
Why?
| Animals | 62 | 2024 | 31694 | 0.800 |
Why?
| Mice, Knockout | 13 | 2024 | 2565 | 0.790 |
Why?
| Immunoglobulin A | 2 | 2022 | 166 | 0.790 |
Why?
| Interferon-beta | 2 | 2020 | 79 | 0.740 |
Why?
| B-Lymphocytes | 6 | 2023 | 766 | 0.710 |
Why?
| Viral Load | 9 | 2021 | 405 | 0.710 |
Why?
| CD8-Positive T-Lymphocytes | 8 | 2021 | 687 | 0.690 |
Why?
| Mice | 27 | 2024 | 14860 | 0.690 |
Why?
| Virion | 4 | 2016 | 73 | 0.670 |
Why?
| Proteins | 6 | 2022 | 908 | 0.650 |
Why?
| Killer Cells, Natural | 5 | 2016 | 380 | 0.640 |
Why?
| Mice, Inbred C57BL | 16 | 2024 | 4689 | 0.640 |
Why?
| Leukemia, Experimental | 4 | 2014 | 27 | 0.620 |
Why?
| Lipopolysaccharides | 1 | 2021 | 821 | 0.610 |
Why?
| RNA, Viral | 9 | 2024 | 565 | 0.580 |
Why?
| Host-Pathogen Interactions | 5 | 2024 | 295 | 0.570 |
Why?
| Enterobacteriaceae | 1 | 2017 | 32 | 0.560 |
Why?
| Receptor, Interferon alpha-beta | 3 | 2024 | 23 | 0.560 |
Why?
| Immunity, Cellular | 2 | 2016 | 248 | 0.520 |
Why?
| Feces | 10 | 2017 | 373 | 0.490 |
Why?
| Immunomodulation | 1 | 2016 | 84 | 0.490 |
Why?
| Immunoglobulin Variable Region | 1 | 2015 | 72 | 0.490 |
Why?
| Immunoglobulin Heavy Chains | 1 | 2015 | 72 | 0.490 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2015 | 35 | 0.480 |
Why?
| Signal Transduction | 6 | 2024 | 4509 | 0.480 |
Why?
| Dysbiosis | 4 | 2022 | 146 | 0.470 |
Why?
| Viremia | 6 | 2020 | 122 | 0.470 |
Why?
| Intestines | 1 | 2017 | 326 | 0.450 |
Why?
| Virus Diseases | 3 | 2022 | 194 | 0.430 |
Why?
| Endoribonucleases | 1 | 2013 | 62 | 0.420 |
Why?
| Antibody Formation | 3 | 2017 | 266 | 0.410 |
Why?
| Endogenous Retroviruses | 1 | 2012 | 19 | 0.390 |
Why?
| Molecular Sequence Data | 15 | 2014 | 2785 | 0.380 |
Why?
| Colon | 4 | 2022 | 233 | 0.360 |
Why?
| Antibody Affinity | 1 | 2010 | 52 | 0.350 |
Why?
| Spleen | 5 | 2018 | 487 | 0.350 |
Why?
| Intestinal Mucosa | 4 | 2019 | 532 | 0.340 |
Why?
| HIV Seropositivity | 2 | 2022 | 109 | 0.340 |
Why?
| Humans | 59 | 2024 | 114623 | 0.340 |
Why?
| Retroviridae | 3 | 2023 | 90 | 0.340 |
Why?
| Antigens, Helminth | 2 | 1999 | 12 | 0.330 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 923 | 0.330 |
Why?
| Cercocebus atys | 3 | 2006 | 6 | 0.330 |
Why?
| HIV-2 | 3 | 2006 | 15 | 0.320 |
Why?
| Schistosomiasis japonica | 2 | 1999 | 32 | 0.320 |
Why?
| Animals, Wild | 3 | 2005 | 44 | 0.320 |
Why?
| Macaca mulatta | 5 | 2021 | 131 | 0.310 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2016 | 1879 | 0.310 |
Why?
| Base Sequence | 7 | 2015 | 2114 | 0.310 |
Why?
| Cells, Cultured | 10 | 2018 | 3881 | 0.310 |
Why?
| Interleukin-15 | 2 | 2021 | 74 | 0.310 |
Why?
| Lymphocytes | 2 | 2021 | 330 | 0.310 |
Why?
| Lymphocyte Activation | 5 | 2017 | 1037 | 0.310 |
Why?
| Antigen Presentation | 2 | 2021 | 188 | 0.300 |
Why?
| Reverse Transcription | 2 | 2021 | 18 | 0.290 |
Why?
| Ape Diseases | 3 | 2008 | 6 | 0.290 |
Why?
| Immunity, Humoral | 2 | 2022 | 112 | 0.290 |
Why?
| Disease Reservoirs | 2 | 2006 | 18 | 0.290 |
Why?
| Gastrointestinal Microbiome | 4 | 2022 | 501 | 0.280 |
Why?
| Flow Cytometry | 4 | 2017 | 1083 | 0.280 |
Why?
| Papillomavirus Infections | 2 | 2022 | 261 | 0.280 |
Why?
| Immunity, Mucosal | 3 | 2020 | 84 | 0.270 |
Why?
| Sequence Analysis, DNA | 5 | 2017 | 723 | 0.270 |
Why?
| Gene Expression Profiling | 5 | 2020 | 1518 | 0.260 |
Why?
| Disease Models, Animal | 5 | 2018 | 3531 | 0.250 |
Why?
| Genetic Variation | 4 | 2015 | 870 | 0.250 |
Why?
| Phylogeny | 13 | 2017 | 789 | 0.250 |
Why?
| Immunoglobulin G | 4 | 2022 | 770 | 0.250 |
Why?
| Mammary Tumor Virus, Mouse | 1 | 2024 | 42 | 0.240 |
Why?
| Frameshifting, Ribosomal | 1 | 2024 | 6 | 0.240 |
Why?
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 92 | 0.240 |
Why?
| HIV Long Terminal Repeat | 1 | 2024 | 8 | 0.240 |
Why?
| Granzymes | 2 | 2022 | 40 | 0.240 |
Why?
| Interferon-gamma | 2 | 2019 | 719 | 0.230 |
Why?
| Alternative Splicing | 2 | 2024 | 187 | 0.230 |
Why?
| Bone Marrow Cells | 3 | 2016 | 267 | 0.230 |
Why?
| Transcriptome | 2 | 2022 | 725 | 0.230 |
Why?
| Immunoglobulin M | 4 | 2022 | 246 | 0.230 |
Why?
| DNA Transposable Elements | 1 | 2024 | 101 | 0.230 |
Why?
| Cercopithecus | 1 | 2003 | 2 | 0.230 |
Why?
| Exons | 1 | 2024 | 302 | 0.220 |
Why?
| DNA, Viral | 3 | 2021 | 350 | 0.220 |
Why?
| NF-kappa B | 2 | 2018 | 638 | 0.210 |
Why?
| Antibodies, Helminth | 2 | 1999 | 6 | 0.200 |
Why?
| Recombination, Genetic | 4 | 2015 | 176 | 0.200 |
Why?
| RNA, Messenger | 3 | 2024 | 2552 | 0.200 |
Why?
| Genome, Viral | 1 | 2003 | 118 | 0.200 |
Why?
| HEK293 Cells | 5 | 2024 | 591 | 0.200 |
Why?
| Male | 21 | 2021 | 55554 | 0.190 |
Why?
| Acute Disease | 2 | 2016 | 910 | 0.190 |
Why?
| Blood | 1 | 2022 | 96 | 0.190 |
Why?
| Viral Regulatory and Accessory Proteins | 2 | 2016 | 26 | 0.190 |
Why?
| Female | 23 | 2024 | 59466 | 0.190 |
Why?
| Ruminococcus | 1 | 2021 | 9 | 0.190 |
Why?
| Acinetobacter | 1 | 2021 | 13 | 0.190 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 127 | 0.190 |
Why?
| Lymphopenia | 1 | 2021 | 49 | 0.190 |
Why?
| Peripheral Tolerance | 2 | 2020 | 14 | 0.190 |
Why?
| Evolution, Molecular | 3 | 2016 | 430 | 0.180 |
Why?
| Specimen Handling | 1 | 2022 | 155 | 0.180 |
Why?
| Bacterial Translocation | 2 | 2019 | 36 | 0.180 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2020 | 13 | 0.170 |
Why?
| Picornaviridae | 1 | 2020 | 17 | 0.170 |
Why?
| Tropomyosin | 1 | 1999 | 12 | 0.170 |
Why?
| Immunologic Factors | 2 | 2019 | 220 | 0.170 |
Why?
| Salmonella typhimurium | 1 | 2021 | 164 | 0.170 |
Why?
| Genotype | 3 | 2013 | 1760 | 0.170 |
Why?
| Cell Line | 6 | 2020 | 2635 | 0.170 |
Why?
| Immunologic Memory | 1 | 2021 | 313 | 0.160 |
Why?
| Keratinocytes | 2 | 2018 | 216 | 0.160 |
Why?
| Interleukin-2 | 2 | 2022 | 413 | 0.160 |
Why?
| Lymph Nodes | 3 | 2018 | 419 | 0.160 |
Why?
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2018 | 1 | 0.160 |
Why?
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2016 | 19 | 0.160 |
Why?
| GPI-Linked Proteins | 2 | 2016 | 54 | 0.160 |
Why?
| Helminth Proteins | 1 | 1999 | 19 | 0.160 |
Why?
| Gram-Positive Bacteria | 1 | 2019 | 45 | 0.160 |
Why?
| Lectins | 1 | 2018 | 42 | 0.160 |
Why?
| Gram-Negative Bacteria | 1 | 2019 | 66 | 0.160 |
Why?
| Protective Agents | 1 | 2018 | 37 | 0.160 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 1998 | 7 | 0.160 |
Why?
| Proteome | 1 | 2022 | 339 | 0.150 |
Why?
| Papillomavirus E7 Proteins | 1 | 2018 | 9 | 0.150 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2018 | 154 | 0.150 |
Why?
| Cullin Proteins | 1 | 2018 | 12 | 0.150 |
Why?
| Human papillomavirus 16 | 1 | 2018 | 25 | 0.150 |
Why?
| HIV | 3 | 2018 | 208 | 0.150 |
Why?
| Human Immunodeficiency Virus Proteins | 2 | 2016 | 6 | 0.150 |
Why?
| APOBEC-1 Deaminase | 2 | 2014 | 5 | 0.150 |
Why?
| Proteolysis | 1 | 2018 | 142 | 0.140 |
Why?
| Viral Tropism | 1 | 2017 | 24 | 0.140 |
Why?
| Immunoglobulin E | 1 | 1999 | 314 | 0.140 |
Why?
| Interleukins | 1 | 2019 | 236 | 0.140 |
Why?
| Case-Control Studies | 2 | 2022 | 3003 | 0.140 |
Why?
| Influenza, Human | 1 | 2022 | 546 | 0.140 |
Why?
| Allergens | 1 | 2020 | 413 | 0.140 |
Why?
| Toll-Like Receptor 7 | 1 | 2016 | 35 | 0.140 |
Why?
| Parvoviridae Infections | 1 | 2016 | 11 | 0.140 |
Why?
| Biological Products | 1 | 2019 | 166 | 0.140 |
Why?
| Disease Resistance | 1 | 2016 | 27 | 0.140 |
Why?
| Mutagenesis, Insertional | 1 | 2016 | 61 | 0.130 |
Why?
| Butyrates | 1 | 2017 | 53 | 0.130 |
Why?
| Interleukin-12 | 1 | 2016 | 110 | 0.130 |
Why?
| Amino Acid Sequence | 6 | 2016 | 1982 | 0.130 |
Why?
| Phenotype | 2 | 2016 | 2796 | 0.130 |
Why?
| Lymphoid Tissue | 2 | 2020 | 62 | 0.130 |
Why?
| B7-1 Antigen | 1 | 2016 | 53 | 0.130 |
Why?
| Primates | 2 | 2015 | 111 | 0.130 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 140 | 0.130 |
Why?
| Neoplasms | 2 | 2022 | 2097 | 0.130 |
Why?
| NIH 3T3 Cells | 1 | 2016 | 137 | 0.130 |
Why?
| Gene Products, nef | 2 | 2006 | 12 | 0.130 |
Why?
| Histones | 1 | 2020 | 535 | 0.130 |
Why?
| Antibody Diversity | 1 | 2015 | 16 | 0.130 |
Why?
| Cell Proliferation | 2 | 2019 | 2186 | 0.130 |
Why?
| Bacteria | 2 | 2022 | 725 | 0.120 |
Why?
| Major Histocompatibility Complex | 1 | 2016 | 217 | 0.120 |
Why?
| Endocytosis | 1 | 2016 | 148 | 0.120 |
Why?
| Toll-Like Receptor 3 | 1 | 2014 | 26 | 0.120 |
Why?
| Colobus | 1 | 2014 | 3 | 0.120 |
Why?
| Prevalence | 4 | 2006 | 2249 | 0.120 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2017 | 339 | 0.120 |
Why?
| Autoimmunity | 1 | 2020 | 813 | 0.120 |
Why?
| Biological Evolution | 2 | 2012 | 416 | 0.110 |
Why?
| Cote d'Ivoire | 2 | 2005 | 8 | 0.110 |
Why?
| Papillomaviridae | 1 | 2014 | 101 | 0.110 |
Why?
| Germinal Center | 1 | 2014 | 48 | 0.110 |
Why?
| Cloning, Molecular | 3 | 2013 | 522 | 0.110 |
Why?
| Gene Frequency | 1 | 2015 | 477 | 0.110 |
Why?
| env Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 16 | 0.110 |
Why?
| APOBEC Deaminases | 2 | 2024 | 5 | 0.110 |
Why?
| Immunization | 2 | 2020 | 397 | 0.110 |
Why?
| Virus Integration | 1 | 2013 | 68 | 0.110 |
Why?
| T-Lymphocyte Subsets | 1 | 2016 | 383 | 0.110 |
Why?
| DNA Damage | 1 | 2015 | 351 | 0.110 |
Why?
| Amino Acids | 1 | 2016 | 448 | 0.110 |
Why?
| Tanzania | 2 | 2003 | 41 | 0.100 |
Why?
| Uganda | 2 | 2003 | 70 | 0.100 |
Why?
| Urine | 2 | 2003 | 54 | 0.100 |
Why?
| Adult | 9 | 2020 | 30528 | 0.100 |
Why?
| Inbreeding | 1 | 2012 | 16 | 0.100 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 439 | 0.100 |
Why?
| Mutation | 3 | 2024 | 3344 | 0.100 |
Why?
| Cell Membrane | 1 | 2016 | 680 | 0.100 |
Why?
| Carcinogenesis | 2 | 2024 | 177 | 0.100 |
Why?
| Down-Regulation | 3 | 2018 | 594 | 0.100 |
Why?
| Young Adult | 4 | 2020 | 10455 | 0.100 |
Why?
| Neutralization Tests | 2 | 2008 | 63 | 0.100 |
Why?
| Middle Aged | 7 | 2020 | 26719 | 0.100 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 396 | 0.090 |
Why?
| Philippines | 3 | 2001 | 50 | 0.090 |
Why?
| Protein Isoforms | 2 | 2024 | 338 | 0.090 |
Why?
| DNA Primers | 3 | 2013 | 510 | 0.090 |
Why?
| B-Cell Activation Factor Receptor | 1 | 2010 | 13 | 0.090 |
Why?
| Gene Expression Regulation | 3 | 2018 | 2319 | 0.090 |
Why?
| CD4 Antigens | 3 | 2006 | 123 | 0.090 |
Why?
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 4 | 0.090 |
Why?
| Leukemia Virus, Murine | 1 | 2010 | 16 | 0.090 |
Why?
| Phenylacetates | 1 | 2010 | 9 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 797 | 0.090 |
Why?
| Cytosine Deaminase | 1 | 2010 | 14 | 0.090 |
Why?
| Leukocytes, Mononuclear | 3 | 2022 | 493 | 0.090 |
Why?
| Nitrophenols | 1 | 2010 | 32 | 0.090 |
Why?
| Gene Products, gag | 1 | 2010 | 36 | 0.090 |
Why?
| Escherichia coli | 1 | 2014 | 720 | 0.090 |
Why?
| T-Lymphocytes | 3 | 2020 | 1736 | 0.080 |
Why?
| Plasma | 1 | 2011 | 211 | 0.080 |
Why?
| Lentivirus | 2 | 2013 | 44 | 0.080 |
Why?
| Sequence Analysis, RNA | 1 | 2011 | 385 | 0.080 |
Why?
| Apoptosis | 3 | 2014 | 2362 | 0.080 |
Why?
| Molecular Epidemiology | 2 | 2006 | 62 | 0.080 |
Why?
| Simian foamy virus | 1 | 2008 | 2 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 3 | 2011 | 353 | 0.080 |
Why?
| Receptors, Antigen, B-Cell | 2 | 2020 | 107 | 0.080 |
Why?
| Immunotherapy | 2 | 2023 | 474 | 0.070 |
Why?
| Inflammation | 1 | 2018 | 2477 | 0.070 |
Why?
| Cross-Sectional Studies | 4 | 2018 | 4405 | 0.070 |
Why?
| Chromosome Mapping | 1 | 2008 | 487 | 0.070 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 1131 | 0.070 |
Why?
| Lentiviruses, Primate | 1 | 2006 | 13 | 0.070 |
Why?
| Genes, env | 1 | 2005 | 4 | 0.060 |
Why?
| Genes, gag | 1 | 2005 | 3 | 0.060 |
Why?
| Blotting, Western | 3 | 2010 | 1147 | 0.060 |
Why?
| Social Dominance | 1 | 2005 | 17 | 0.060 |
Why?
| Disease Transmission, Infectious | 1 | 2005 | 55 | 0.060 |
Why?
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2024 | 18 | 0.060 |
Why?
| RNA Transport | 1 | 2024 | 23 | 0.060 |
Why?
| Poliovirus Vaccine, Oral | 1 | 2004 | 19 | 0.060 |
Why?
| Jurkat Cells | 1 | 2024 | 128 | 0.060 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2005 | 152 | 0.060 |
Why?
| Dependovirus | 2 | 2016 | 52 | 0.060 |
Why?
| Time Factors | 1 | 2014 | 6112 | 0.060 |
Why?
| Cell Survival | 2 | 2019 | 1020 | 0.060 |
Why?
| Disease Outbreaks | 1 | 2006 | 307 | 0.050 |
Why?
| Endemic Diseases | 1 | 2003 | 23 | 0.050 |
Why?
| Retroviridae Proteins | 1 | 2003 | 11 | 0.050 |
Why?
| Mice, Transgenic | 2 | 2020 | 1947 | 0.050 |
Why?
| Recombinant Proteins | 2 | 2018 | 1230 | 0.050 |
Why?
| Serine-Arginine Splicing Factors | 1 | 2022 | 18 | 0.050 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 217 | 0.050 |
Why?
| Cytidine | 1 | 2022 | 3 | 0.050 |
Why?
| Apolipoproteins | 1 | 2022 | 36 | 0.050 |
Why?
| Polymerase Chain Reaction | 2 | 2002 | 993 | 0.050 |
Why?
| Wuchereria bancrofti | 1 | 2001 | 2 | 0.050 |
Why?
| Filariasis | 1 | 2001 | 4 | 0.050 |
Why?
| Datasets as Topic | 1 | 2022 | 99 | 0.050 |
Why?
| DNA, Helminth | 1 | 2001 | 16 | 0.050 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 796 | 0.050 |
Why?
| Macrophages | 2 | 2018 | 1261 | 0.050 |
Why?
| World Health Organization | 1 | 2022 | 102 | 0.050 |
Why?
| Immunoblotting | 1 | 2002 | 283 | 0.050 |
Why?
| Lymphocyte Depletion | 1 | 2021 | 116 | 0.050 |
Why?
| Hemagglutination | 1 | 2020 | 7 | 0.050 |
Why?
| Antibodies | 1 | 2022 | 371 | 0.040 |
Why?
| COS Cells | 1 | 2020 | 175 | 0.040 |
Why?
| Immune Evasion | 1 | 2020 | 47 | 0.040 |
Why?
| Snails | 1 | 1999 | 32 | 0.040 |
Why?
| Gene Library | 1 | 1999 | 114 | 0.040 |
Why?
| Toll-Like Receptors | 1 | 2020 | 167 | 0.040 |
Why?
| Recombinant Fusion Proteins | 2 | 2016 | 616 | 0.040 |
Why?
| Erythroblasts | 1 | 2018 | 12 | 0.040 |
Why?
| CD4 Lymphocyte Count | 2 | 2014 | 257 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2003 | 1691 | 0.040 |
Why?
| Nucleic Acid Heteroduplexes | 1 | 1998 | 8 | 0.040 |
Why?
| Disease Progression | 2 | 2016 | 2380 | 0.040 |
Why?
| Sex Work | 1 | 1998 | 18 | 0.040 |
Why?
| Interferon Regulatory Factor-7 | 1 | 2018 | 4 | 0.040 |
Why?
| Rabbits | 1 | 1999 | 733 | 0.040 |
Why?
| Inpatients | 1 | 2022 | 380 | 0.040 |
Why?
| Sendai virus | 1 | 2018 | 15 | 0.040 |
Why?
| THP-1 Cells | 1 | 2018 | 19 | 0.040 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2018 | 52 | 0.040 |
Why?
| Enzyme Stability | 1 | 2018 | 62 | 0.040 |
Why?
| I-kappa B Kinase | 1 | 2018 | 50 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2018 | 133 | 0.040 |
Why?
| Antigenic Variation | 1 | 1997 | 9 | 0.040 |
Why?
| Antigens, Protozoan | 1 | 1997 | 19 | 0.040 |
Why?
| Autoantigens | 1 | 2020 | 396 | 0.040 |
Why?
| Palatine Tonsil | 1 | 2017 | 32 | 0.040 |
Why?
| Anti-Retroviral Agents | 1 | 2019 | 207 | 0.040 |
Why?
| Gene Silencing | 1 | 2018 | 171 | 0.040 |
Why?
| Plasmodium falciparum | 1 | 1997 | 27 | 0.040 |
Why?
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2017 | 13 | 0.040 |
Why?
| Malaria, Falciparum | 1 | 1997 | 25 | 0.040 |
Why?
| Cross Reactions | 1 | 2017 | 117 | 0.040 |
Why?
| HIV Envelope Protein gp120 | 1 | 2017 | 56 | 0.040 |
Why?
| Ki-67 Antigen | 1 | 2017 | 103 | 0.040 |
Why?
| Antigens, Surface | 1 | 1997 | 146 | 0.040 |
Why?
| Protozoan Proteins | 1 | 1997 | 62 | 0.030 |
Why?
| Models, Biological | 1 | 2004 | 1620 | 0.030 |
Why?
| Peptides | 1 | 2022 | 848 | 0.030 |
Why?
| DNA, Ribosomal | 1 | 2017 | 79 | 0.030 |
Why?
| Receptors, CXCR4 | 1 | 2017 | 78 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2019 | 370 | 0.030 |
Why?
| APOBEC-3G Deaminase | 1 | 2016 | 6 | 0.030 |
Why?
| Myxovirus Resistance Proteins | 1 | 2016 | 8 | 0.030 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 90 | 0.030 |
Why?
| Sequence Deletion | 1 | 2016 | 167 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2016 | 197 | 0.030 |
Why?
| DNA, Mitochondrial | 2 | 2008 | 182 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2018 | 399 | 0.030 |
Why?
| Imidazoles | 1 | 2016 | 208 | 0.030 |
Why?
| DNA, Bacterial | 1 | 2017 | 311 | 0.030 |
Why?
| Cluster Analysis | 1 | 2017 | 455 | 0.030 |
Why?
| Protein Transport | 1 | 2016 | 395 | 0.030 |
Why?
| Receptors, CXCR5 | 1 | 2014 | 11 | 0.030 |
Why?
| Receptors, CCR7 | 1 | 2014 | 24 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 1036 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2017 | 485 | 0.030 |
Why?
| Cervix Uteri | 1 | 2014 | 45 | 0.030 |
Why?
| Viral Proteins | 1 | 2016 | 281 | 0.030 |
Why?
| Sexual Behavior | 1 | 1998 | 440 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2020 | 1262 | 0.030 |
Why?
| Antigens, Viral | 1 | 2014 | 176 | 0.030 |
Why?
| Phosphorylation | 1 | 2018 | 1569 | 0.030 |
Why?
| Vaccines | 1 | 1999 | 375 | 0.030 |
Why?
| Caspase 1 | 1 | 2014 | 140 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 270 | 0.030 |
Why?
| Mucous Membrane | 1 | 2014 | 108 | 0.030 |
Why?
| Genetic Engineering | 1 | 2013 | 80 | 0.030 |
Why?
| Sequence Alignment | 1 | 2013 | 323 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2014 | 1016 | 0.020 |
Why?
| Cytokines | 1 | 2019 | 1840 | 0.020 |
Why?
| Retroelements | 1 | 2011 | 39 | 0.020 |
Why?
| HIV Reverse Transcriptase | 1 | 2010 | 29 | 0.020 |
Why?
| Aged | 2 | 2017 | 19061 | 0.020 |
Why?
| Cell Movement | 1 | 2014 | 868 | 0.020 |
Why?
| Glycosylation | 1 | 2010 | 130 | 0.020 |
Why?
| L-Selectin | 1 | 2009 | 25 | 0.020 |
Why?
| Autoantibodies | 1 | 2017 | 1345 | 0.020 |
Why?
| HIV Core Protein p24 | 1 | 2009 | 28 | 0.020 |
Why?
| Child | 2 | 2017 | 18404 | 0.020 |
Why?
| Microbiota | 1 | 2017 | 647 | 0.020 |
Why?
| DNA Replication | 1 | 2010 | 202 | 0.020 |
Why?
| Infant, Newborn | 1 | 1999 | 5043 | 0.020 |
Why?
| Aged, 80 and over | 1 | 1999 | 6344 | 0.020 |
Why?
| Africa, Central | 1 | 2008 | 3 | 0.020 |
Why?
| Genetics, Microbial | 1 | 2008 | 9 | 0.020 |
Why?
| Adolescent | 2 | 2012 | 17831 | 0.020 |
Why?
| HLA-DR Antigens | 1 | 2009 | 219 | 0.020 |
Why?
| Ecology | 1 | 2008 | 95 | 0.020 |
Why?
| Gene Products, pol | 1 | 2007 | 6 | 0.020 |
Why?
| Consensus Sequence | 1 | 2007 | 70 | 0.020 |
Why?
| Prospective Studies | 1 | 1998 | 6217 | 0.020 |
Why?
| Infant | 1 | 1999 | 7959 | 0.020 |
Why?
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2006 | 7 | 0.020 |
Why?
| Cameroon | 1 | 2006 | 8 | 0.020 |
Why?
| Child, Preschool | 1 | 1999 | 9108 | 0.020 |
Why?
| HIV Antibodies | 1 | 2006 | 49 | 0.020 |
Why?
| Risk Factors | 1 | 1998 | 8628 | 0.020 |
Why?
| Protein Binding | 1 | 2010 | 1889 | 0.020 |
Why?
| Haplotypes | 1 | 2006 | 448 | 0.010 |
Why?
| p21-Activated Kinases | 1 | 2004 | 14 | 0.010 |
Why?
| CD28 Antigens | 1 | 2004 | 47 | 0.010 |
Why?
| Africa, Western | 1 | 2004 | 16 | 0.010 |
Why?
| Mutagenesis, Site-Directed | 1 | 2005 | 345 | 0.010 |
Why?
| Ecosystem | 1 | 2008 | 502 | 0.010 |
Why?
| HeLa Cells | 1 | 2005 | 562 | 0.010 |
Why?
| Green Fluorescent Proteins | 1 | 2005 | 371 | 0.010 |
Why?
| Transfection | 1 | 2005 | 866 | 0.010 |
Why?
| Histocompatibility Antigens Class II | 1 | 2004 | 352 | 0.010 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 16 | 0.010 |
Why?
| Africa | 1 | 2001 | 94 | 0.010 |
Why?
| Malaria Vaccines | 1 | 1997 | 6 | 0.010 |
Why?
| DNA, Protozoan | 1 | 1997 | 26 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2004 | 2762 | 0.010 |
Why?
| Point Mutation | 1 | 1997 | 216 | 0.010 |
Why?
| Epitopes | 1 | 1997 | 435 | 0.010 |
Why?
|
|
Santiago's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|